Prof David Gyorki
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
236 Scholarly works
4 Projects
HIGHLIGHTS
2026
Journal article
ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.
DOI: 10.1245/s10434-025-19025-72026
Journal article
Pathologic Assessment of Retroperitoneal Sarcomas
DOI: 10.1097/PAS.00000000000025002026
Journal article
ASO Visual Abstract: Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients With Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial.
DOI: 10.1245/s10434-026-19430-62026
Journal article
International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.
DOI: 10.1245/s10434-025-18475-32021
Research grants (ARC, NHMRC, MRFF)
A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients With High Risk RetroPeritoneal Sarcoma (STRASS 2)
2019
Research grants (ARC, NHMRC, MRFF)
Melanoma Margins Trial-Ii: A Phase Iii, Multi-Centre Randomised Controlled Trial Investigating 1cm vs 2cm Wide Surgical Excision Margins for Ajcc Stage Ii Primary Cutaneous Melanoma (Melmart-Ii)
2018
Research Grant
Novel Therapies to Enhance Anti-Tumour Immunity
RECENT SCHOLARLY WORKS
2026
Journal article
Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis
DOI: 10.1016/j.eclinm.2026.1038052026
Journal article
The role of multivisceral resection on outcomes in primary retroperitoneal sarcoma: A systematic review by the Australian and New Zealand Sarcoma Association Clinical Practice Guidelines Working Party
DOI: 10.1016/j.soi.2025.1002082026
Journal article
178P Treatment patterns and outcomes for patients with abdominal, pelvic and retroperitoneal leiomyosarcoma and liposarcoma: an Australian sarcoma centre experience
DOI: 10.1016/j.esmorc.2026.1003842026
Conference Proceedings
International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma
DOI: 10.1245/s10434-025-18475-32026
Journal article
Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic retroperitoneal sarcoma working group (TARPSWG)
DOI: 10.1016/j.ctrv.2025.1030862026
Journal article
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
DOI: 10.1016/j.annonc.2025.10.1237
RECENT PROJECTS
2019
Research grants (ARC, NHMRC, MRFF)
A Randomised Phase II Trial of Adjuvant Avelumab in Patients With Early Stage Merkel Cell Carcinoma